An object of the present invention is to provide a novel metal-organic framework with a dicarboxylic acid having a terphenyl skeleton as an organic ligand and a gas storage method using such a metal-organic framework. A metal-organic framework comprising a carboxylate ion of formula (I) and a multivalent metal ion bonded to each other. (In formula (I), R.sup.1 and R.sup.2 each independently are a hydroxy group or an unsubstituted or substituted C1-6 alkyl group. R.sup.10 and R.sup.11 each independently are an unsubstituted or substituted C1-6 alkyl group. R.sup.20 is an unsubstituted or substituted C1-6 alkyl group. Provided that, as substituents on R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.10, R.sup.11, and R.sup.20, a carboxy group (COOH) and a carboxylate ion group (COO—) are excluded. In addition, R.sup.10 and R.sup.11 are not a methyl group at the same time.)

##STR00001##

The present invention relates to a synthesis of novel Zn(II)-based Metal Organic Frameworks having mixed organic ligands of 1,3,5-benzene tricarboxylic acid (BTC) and 2-methylimidazole (mIm) through a simple and economic solvothermal method. The synthesized MOFs has cuboids morphology having high surface area (1248 m2/g) capable of hydrogen adsorption at −10° C. to 25° C. temperature and 100 bar pressure. The hydrogen adsorption capabilities of the novel MOFs are in the range of 23-0.2 weight percent.

The present invention relates to a synthesis of novel Zn(II)-based Metal Organic Frameworks having mixed organic ligands of 1,3,5-benzene tricarboxylic acid (BTC) and 2-methylimidazole (mIm) through a simple and economic solvothermal method. The synthesized MOFs has cuboids morphology having high surface area (1248 m2/g) capable of hydrogen adsorption at −10° C. to 25° C. temperature and 100 bar pressure. The hydrogen adsorption capabilities of the novel MOFs are in the range of 23-0.2 weight percent.

The present invention relates to a process for preparing substituted imidazole derivatives of the formula (II) ##STR00001##
from compounds of the formula (I) ##STR00002##
via intermediates of the formula (IVa) or (IVb) ##STR00003##
in which the structural elements shown in the formulae (I), (II), (IVa) and (IVb) have the meanings given in the description. Furthermore, the invention relates to the intermediates of the formulae (IVa) and (IVb).

The present invention relates to a process for preparing substituted imidazole derivatives of the formula (II) ##STR00001##
from compounds of the formula (I) ##STR00002##
via intermediates of the formula (IVa) or (IVb) ##STR00003##
in which the structural elements shown in the formulae (I), (II), (IVa) and (IVb) have the meanings given in the description. Furthermore, the invention relates to the intermediates of the formulae (IVa) and (IVb).

A pyrazole metal complex for absorption of carbon dioxide, a method for preparing the pyrazole metal complex, and a method for absorbing carbon dioxide are provided; wherein the product produced by reacting pyrazole metal complex and carbon dioxide may be transformed into several economically valuable compounds.

A pyrazole metal complex for absorption of carbon dioxide, a method for preparing the pyrazole metal complex, and a method for absorbing carbon dioxide are provided; wherein the product produced by reacting pyrazole metal complex and carbon dioxide may be transformed into several economically valuable compounds.

The present invention relates to precursor compounds, and more particularly to nonpyrophoric precursor compounds suitable for use in thin film deposition through atomic layer deposition (ALD) or chemical vapor deposition (CVD), and to an ALD/CVD process using the same.

The present invention relates to precursor compounds, and more particularly to nonpyrophoric precursor compounds suitable for use in thin film deposition through atomic layer deposition (ALD) or chemical vapor deposition (CVD), and to an ALD/CVD process using the same.

The invention relates to ligands able to bind to microvesicles, comprising a plurality of metal(II)-dipicolylamine moieties and their use in the diagnosis or prognostic of disorders in a subject.